Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).


CSE:RVV - Post by User

Comment by 1ottrunneron May 04, 2021 8:34pm
85 Views
Post# 33129469

RE:$RVV $RVVTF - cut & paste post as usual .. from Yahoo !

RE:$RVV $RVVTF - cut & paste post as usual .. from Yahoo !FALSE 1. This is not almost as good as EUA, that's idiotic 2. The fact did NOT expand the trial I'll end there. You realize that people are remortgaging their homes, ya? On bad DD. Moron.
cool888 wrote: "starting a trial for severe covid, the update never said that, it just said the current phase 3 clincial trial ''will position Bucillamine as a potential oral treatment option for mild-moderate to severe COVID-19'' this update is even better than expected and i reckon nearly as good as EUA, the FDA just expanded the trail parameters because bucillamine is obviously working, just how good are those thiols at working against this life sucking covid 19??? All the research is pointing at this being the real deal. this + the way the chart is looking / we are retesting the breakout above .485 downward trend yday, if we hold that at + .49 we are flying it, and could get some serious gap ups very soon. When this gets even more institutional (cannacord etc) and retail hype, + EUA covid vaccine or viral approval, we will be +$10 i reckon, if OCGN can do it on less,we should be able to the same if not surpass it in similar mkt environment..... glta"


<< Previous
Bullboard Posts
Next >>